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ABSTRACT
This study was designed to shed light on whether differences in utilization of genetic testing by African-Amer-
icans, Latinos, and non-Hispanic Whites are due primarily to different preferences, or whether they instead
reflect other values and beliefs or differential access. It explores the values, attitudes, and beliefs of African-
Americans, Latinos, and non-Hispanic Whites with respect to genetic testing by means of a telephone survey
of representative samples of these three groups. The study finds clear evidence that Latinos and African-
Americans are, if anything, more likely to express preferences for both prenatal and adult genetic testing than
White respondents. At the same time, they hold other beliefs and attitudes that may conflict with, and over-
ride, these preferences in specific situations. African-Americans and Latinos are also less knowledgeable about
genetic testing than non-Hispanic Whites, and they are less likely to have the financial resources or insurance
coverage that would facilitate access to testing.
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THEORETICAL CONSIDERATIONS
PRENATAL GENETIC TESTING and genetic testing for adultsraise a number of issues relevant to the provision of health
care as well as the formulation of public policy. So far as pub-
lic policy is concerned, the issues that will have to be addressed
have to do with insurability (for example, to what extent ge-
netic conditions will be considered pre-existing conditions, and
with what implications for insurability, coverage, and rates for
both health and life insurance), privacy (how information about
genetic heritage can be protected against intrusion), and dis-
crimination (preventing employers and insurance companies,
for example, from discriminating against individuals on the ba-
sis of genetic information; see Canter, 1984; Draper, 1986,
1991; Uzych, 1986; U.S. Congress, 1990; Billings et al., 1992).
So far as health care is concerned, the issues that arise have to
do with access to care—e.g., assuring equitable access to ge-
netic screening and testing as well as prenatal diagnosis, re-
gardless of the ability to pay—and the relative allocation of
health care funds to these technologies versus other types of
preventive medical care (e.g., should everyone, or only women
at high risk, have access to prenatal testing; should all women,
or only those at high risk, be offered testing for the breast/ovar-
ian cancer gene? See Institute of Medicine, 1994).
Racial and ethnic disparities in health care and health status
are well documented (Williams and Collins, 1995; Williams,
1999; Krieger and Williams, 2001; Williams, 2001, 2002). Such
disparities have also been noted with respect to prenatal genetic
testing, which makes possible the diagnosis of a wide variety
of genetic diseases and conditions and, in some cases, preven-
tive or therapeutic action. For example, Brett et al. (1994)
found, based on an analysis of 1990 birth records, that African-
American women were significantly less likely to use amnio-
centesis than White women were—10.9% compared with
23.2%.
One question that has been raised about this finding is
whether the discrepancy in use of prenatal testing is due pri-
marily to differential preferences on the part of Whites and
African-Americans, or whether it instead reflects differential
access to such care. More generally, the question can be raised
whether racial differences in use of prenatal testing reflect dif-
ferences in culture (i.e., values and belief systems) between
Whites and African-Americans, or whether such differences in-
stead reflect differences in social structure (i.e., the differential
location of members of the two groups in hierarchies of wealth,
prestige, and power).
Some arguments that have been made for the role of values
and belief systems cite the greater religiosity of African-Amer-
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icans, as well as their greater distrust of social institutions, as
factors militating against their use of genetic technology (Cit-
rin et al., 2001). Earlier studies of abortion attitudes, for ex-
ample, have noted that African-American women were gener-
ally less supportive of legalized abortion than White women
(Combs and Welch, 1982; Hall and Ferree, 1986), even though
they are more than twice as likely to undergo abortions (Wilcox,
1990; www.cdc.gov). Others have cited concerns on the part of
minorities that genetic testing might be used to justify increased
racial and ethnic discrimination (Nelkin and Tancredi, 1989;
Nelkin and Lindee, 1995; Citrin et al., 2001).
Over and against these arguments, however, is evidence that
African-Americans have lower incomes, higher unemployment,
and less access to health insurance and medical care than Whites
(see Williams, 2002, esp. p. 593, and the references cited
therein). The fact that they are less likely to make use of diag-
nostic and preventive health care may, therefore, be due less to
their “distrust of the system” than to their inability to gain ac-
cess to it.
The present study was designed to shed light on this issue.
Although many scattered survey questions have been asked
about various aspects of genetics and genetic testing (for a sum-
mary, see Singer et al., 1998), very few comprehensive studies
have focused on this issue (but see Singer, 1991; Croyle and
Lerman, 1993; Andrykowski et al., 1996, 1997; Wertz, 1997;
Singer et al., 1999), and none have had large enough samples
of ethnic or racial minorities to permit separate analyses of these
groups. Accordingly, we decided to include enough African-
Americans as well as Latinos, who are a large and rapidly grow-
ing ethnic group in the United States, to permit separate analy-
ses of their responses as well as comparisons between them and
non-Hispanic White respondents. We did not, however, attempt
to sample different subgroups of the Latino population. Note
that in 2000, 35.3 million of 281.4 million (12.5%) U.S. resi-
dents identified themselves as Spanish/Hispanic/Latino. Mexi-
cans made up 7.3% of the population; Puerto Ricans, 1.2%;
Cubans, 0.4%; other Hispanics, 3.6%. An additional 3.8 mil-
lion residents were enumerated in Puerto Rico. The Hispanic
population increased by 57.9% since 1990, compared with 
an increase of 13.2% for the total U.S. population (see
http://www.census.gov/prod/2001pubs/c2kbr01-3.pdf).
This study provides information about the beliefs of African-
Americans, non-Hispanic Whites (hereafter, Whites), and Lati-
nos with respect to both prenatal and adult genetic testing. The
paper compares the three ethnic-racial groups with respect to
(1) their beliefs and values about genetic technology and (2)
potential barriers to testing. If there are, in fact, no differences
in key elements of these beliefs, the argument that it is culture
rather than structure that determines differential use of genetic
technology loses much of its force. Such a finding would not
prove that differential access, rather than different values and
beliefs, determines actual use of genetic testing, but it would
call the explanation in terms of different values and beliefs into
question.
METHODS
From April 21 through November 26, 2000, the University
of Maryland Survey Research Center (SRC) surveyed repre-
sentative samples of three U.S. populations: the national pop-
ulation of all adults 18 or older residing in telephone house-
holds; the adult Latino population in telephone households;
and the adult African-American population in telephone
households. All three samples were obtained using a two-stage
sample design. The first stage used a list-assisted Plus One
Random-Digit Dial (RDD) frame for household selection. In
each selected household, respondents were then randomly
chosen using a household roster. For the Latino sample, the
RDD frame was stratified to heavily sample states known to
include most (70%) of the Latino population (Texas, Califor-
nia, Florida, and New York). For both the Latino and the
African-American samples, numbers were proportionately
stratified by exchange, based on the estimated percentage of
numbers in the exchange belonging to the target group. (A to-
tal of 4378 telephone numbers was released; 1795 were known
to be non-households; for 344, household status was unknown.
The response rate calculated by American Association for
Public Opinion Research (AAPOR) standards, which assume
that a proportion of unknown telephone numbers are house-
holds, is 51–52%.)
Prior to data collection, each household in the general pop-
ulation sample for which an address could be obtained was sent
an advance letter describing the survey and eliciting coopera-
tion; a $5 incentive was included with each letter. If a respon-
dent refused, another letter, but no additional incentive, was
mailed to households that had received an advance letter. Late
in the study, households that refused and had not received an
advance letter or incentive were offered $10 for their coopera-
tion. Because the advance incentive procedure would have been
inefficient with the Latino and African-American samples
(since many households would have been screened out as inel-
igible), we offered all refusing households in these samples an
incentive of $10.
For the general population sample, we obtained 1232 inter-
views; the SRC standard response rate (which assumes all tele-
phone numbers of unknown household status after 20 attempts
to be non-households) is 55%. For the Latino sample, 321 in-
terviews were obtained, for a cooperation rate of 76%; and for
the African-American sample, 273 interviews were obtained,
for a cooperation rate of 83%. (Because most of the nonre-
sponse in these samples is attributable to inability to contact the
household to screen for eligibility, the AAPOR response rate
for the Latino sample is only 28% and for the African-Ameri-
can sample, 45%.) For the analyses reported in this paper, re-
spondents in the two special samples were combined with
Latino and African-American respondents in the national sam-
ple to create four non-overlapping groups consisting of 428
Latinos, 375 African-Americans, 960 non-Hispanic Whites, and
48 respondents who identified themselves as “other” race. (Re-
sults for this group are not shown in the analyses reported here.)
Respondents who identified themselves as both black and His-
panic were classified as Hispanic; there were 41 such respon-
dents. Unweighted data were used in the analyses for this pa-
per.
The interview, averaging 26.6 min, replicated questions that
had been asked on a survey of public attitudes toward genetics
carried out by Singer in 1990 (Singer, 1991, 1993), and added
others appropriate to scientific developments and policy issues
that had come to the fore since then. Where possible, we re-
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peated questions that had been used in earlier surveys (Singer
et al., 1998). We also, however, relied on two kinds of ex-
ploratory work to make sure that questions were relevant to,
and comprehended by, Latino and African-American respon-
dents. In the first place, Singer and Antonucci participated as
co-investigators in a study of attitudes toward genetic testing
among members of African-American and Latino community
groups in Michigan (Citrin et al., 2001; Singer et al., 2001).
Some of the issues asked about in the present study—for ex-
ample, the statements concerning possible misuse of genetic in-
formation—are directly derived from discussions in these
groups. Second, the questionnaire was tested by means of cog-
nitive interviews with 15 African-American and Latino re-
spondents and revised several times to improve its comprehen-
sibility. All questions used in the analysis are quoted in full
either in the text or in a footnote.
We also prepared a Spanish-language version of the ques-
tionnaire. The Spanish-language version was prepared by a
translator at the Gallup Organization and checked through back-
translation by a bilingual interviewer at the University of Michi-
gan Survey Research Center. Almost half of the respondents
who identified themselves as Hispanic were interviewed in the
Spanish-language version of the questionnaire. For 185 re-
spondents, the interview was conducted entirely in Spanish; for
15 others, it was conducted partly in Spanish and partly in En-
glish. The Spanish-language version of the questionnaire was
offered to respondents at the discretion of the interviewer. If no
bilingual interviewer was immediately available, the case was
set aside for later recontact.
About half of the interviewers on the study were African-
American, but we did not attempt to match respondents and in-
terviewers by race.
The tables below show responses for each of the three
race/ethnic groups to each question analyzed. Also shown for
each question is the significance of the difference between the
responses of White respondents and African-American respon-
dents and between Whites and Latinos. These significance lev-
els reflect controls for education, age, language of interview,
gender, marital status, having children, religion, and frequency
of religious attendance in addition to race and ethnicity. For
simplicity, these control variables are not shown in the tables,
but discussions of significant differences in the text are based
on regression equations that include these control variables.
Analyses are based on either logistic or least-squares regression
depending on whether the dependent variable is dichotomous
or continuous. (When the dependent variable is a frequency
count, we also estimated Poisson regressions. The results do
not change in any significant way when this is done.) For most
Yes–No and Agree–Disagree questions, one response category
is modeled against all others, including Don’t Know and Re-
fused. For questions where the dependent variable is an ordered
response scale, ordered logit models were run.
BELIEFS AND VALUES WITH RESPECT 
TO GENETIC TESTING
In this section, we discuss beliefs and values about genetic
technology under the following headings: Preferences for pre-
natal testing and abortion; preferences for genetic testing for
adults; and beliefs and attitudes about other aspects of genetic
testing.
Preferences for prenatal testing and abortion
All respondents, whether they were male or female and
whether or not they were of childbearing age, were asked about
their preferences for prenatal testing. This question came after
a series of others that defined genetic testing, asked about gen-
eral attitudes toward testing, and measured the accuracy of re-
spondents’ knowledge about testing; these questions are dis-
cussed later in the paper. The question about prenatal testing
read as follows, with wording varied depending on whether the
respondent was a man or a woman:
Today, prenatal tests are being developed that make it pos-
sible to detect many serious genetic defects before a baby
is born, but so far it is impossible to treat or correct most
of them. These next questions are about prenatal genetic
tests, that is, tests during pregnancy for genetic defects in
the baby. If [you/your partner] were pregnant, would [you
want/you want your partner] to have a test to find out if
the baby has any serious genetic defects?
Almost two-thirds of the national sample (66.2%) said they
would want a prenatal genetic test if they or their partner were
pregnant, a slight increase, from 63.6% (p , 0.05), since the
last time this question had been asked, in 1996 (Singer et al.,
1999). White respondents were significantly less likely to ex-
press a preference for prenatal testing than either African-Amer-
ican or Latino respondents, even with other demographic char-
acteristics held constant (see Table 1). There is, thus, no
indication in the present study that Latinos and African-Amer-
icans are less likely to want prenatal testing than Whites.
In data not shown in Table 1, only 59.3% of White respon-
dents and 34.3% of Latino respondents expressed a preference
for prenatal testing for cystic fibrosis, a disease primarily af-
fecting Whites. But more than three-quarters (78.1%) of
African-Americans said they would want prenatal testing for
sickle cell anemia, a disease primarily of African-Americans,
compared with only 37.1% of Latino respondents. (Whites were
not asked about sickle cell anemia, and African-Americans were
not asked about cystic fibrosis.)
These findings suggest that a desire for prenatal testing for
sickle cell anemia may be one reason that African-Americans
are more likely to express a preference for prenatal testing than
Whites. (We had informed respondents early in the question-
naire that “Sickle cell anemia is a genetic blood disease that af-
fects primarily African-Americans.”) But they also indicate that
preferences for prenatal testing vary depending on how the
question is framed. In the abstract, about two-thirds of all re-
spondents say they would want prenatal testing. But depending
on what disease is specified, these percentages can be drasti-
cally reduced or sharply increased.
Respondents who said they themselves would want a prena-
tal test for either cystic fibrosis or sickle cell anemia were then
asked, “Do you think all women who are expecting a baby have
a responsibility to get such a prenatal genetic test, or don’t you
think so?” Of Whites who themselves wanted a test for cystic
fibrosis, only a minority (40.9%) thought all women should be
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tested, compared with 68% of Latinos; among African-Ameri-
cans and Latinos who wanted to be tested for sickle cell ane-
mia, 66.2% and 74.2%, respectively, felt all women had a re-
sponsibility to do so. Differences between Whites and the other
two groups are statistically significant, even with other demo-
graphic characteristics controlled. This finding, like others to
be reviewed later, suggests that both Latino and African-Amer-
ican respondents may feel a greater obligation toward others
than White respondents, who tend to be more individualistic in
their outlook.
Differences by race in preference for prenatal testing are re-
flected in preferences for abortion in case of serious fetal de-
fect. We asked about abortion in two ways, using the word
“abortion” in one version of the question and referring to it as
“ending the pregnancy” in the other. The latter question asked:
Suppose the prenatal test shows the baby has a serious ge-
netic defect. Would [you want/you want your partner] to
end the pregnancy if a test shows the baby has a serious
genetic defect?
Between 21% and 25% of respondents, depending on
race/ethnicity, opted for “abortion,” and between 24% and 29%,
again depending on race/ethnicity, opted for “ending the preg-
nancy.” Neither the effect of form, nor the interaction between
race and form, was significant, and we therefore combined the
responses to the two versions of the question. As can be seen
from Table 1, when other variables are controlled, White re-
spondents are significantly less likely than African-American
respondents and Latino respondents to say they would want an
abortion under these circumstances.
In addition to asking about abortion in case of “serious ge-
netic defect” we also asked:
If a prenatal genetic test showed a high chance of the fol-
lowing, for which situations, if any, would you consider
ending the pregnancy?
Only “ending the pregnancy” was asked about. The follow-
ing six hypothetical situations were asked about: The child
would die before the age of 5; the child would be severely men-
tally retarded; the child would develop a disease causing death
as a young adult; the child would suffer from depression; the
child would be homosexual; the child would not be the sex you
had hoped for. Half the sample was asked the questions in this
order, and half in the reverse order; the effect of question or-
der was not significant, and we therefore combined responses
to the two versions of the question. Respondents who had in-
dicated, in response to the earlier question about abortion/end-
ing the pregnancy that they would not consider abortion under
any circumstances were not asked these questions; there were
130 such respondents.
The mean number of situations for which respondents would
consider an abortion was 0.87 among Whites, 0.95 among
African-Americans, and 0.99 among Latinos; differences be-
tween Whites and African-Americans were significant and
those between Latinos and Whites were marginally significant.
Thus, White respondents in the present study were less likely
than either Latino or African-American respondents to express
a preference for both prenatal testing and abortion.
The condition for which the largest proportion of the sam-
ple (33.7%) would choose to end the pregnancy was mental re-
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TABLE 1. ATTITUDES TOWARD PRENATAL TESTING AND ABORTION, BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
African-Americana Latinoa Whitea African-American Latino
Attitude (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
Want prenatal test 76.3% 73.8% 65.5% ,0.01 ,0.05
Want abortion/ 23.3% 27.0% 23.0% ,0.05 ,0.05
end pregnancy
Abortion Index 0.95 0.99 0.87 ,0.01 ,0.10
(Mean # of conditions for
which respondent would 
want to end pregnancy)
Believes testing for height, 72% 60% 80.6% ,0.05 ,0.10
weight and hair color would
do more harm than good
Believes testing for 60.3% 49.2% 75.5% ,0.01 ,0.01
homosexuality would do
more harm than good
Believes testing for 49.2% 37.4% 59.2% ,0.10 ,0.05
criminality would do more
harm than good
Believes testing for shyness 49.2% 43.6% 58.9% ,0.05 ,0.10
would do more harm than good
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
tardation, which was also the condition most respondents men-
tioned, in response to an open-ended question, when asked to
identify the “serious defect” they had in mind in connection
with a prenatal test. However, as many as 4.2% said they would
end the pregnancy if the child were to be homosexual, and 2.1%
said they would end the pregnancy if the child were not the sex
they had hoped for.
We also asked respondents’ opinion about genetic tests for
things like height, weight, and hair color, considered by some
as a potential misuse of genetic testing. Respondents were asked
whether they thought such tests would do more good than harm,
or more harm than good. Overwhelmingly, some three-quarters
of the sample thought such tests would do more harm than good,
but White respondents were significantly more likely to con-
sider such tests harmful than African-American respondents and
marginally more likely to do so than Latino respondents. They
were also significantly more likely to believe that tests for ho-
mosexuality, criminality, and shyness would do more harm than
good. Thus, although African-American and Latino participants
in the Michigan discussion groups were very sensitive to eu-
genic implications of genetic testing (Citrin et al., 2001), the
current national survey indicates that under certain circum-
stances White respondents are even more sensitive to such con-
siderations.
To clarify these responses, a random subsample of respon-
dents was asked the reason for their answer. Among the most
common reasons given for considering the tests harmful was a
belief that they would lead to eugenic selection (36% of the re-
sponses) and a statement that genetic tests should be done only
for health reasons (9%), or that they were not needed (26%).
Other reasons made reference to God, religion, morals, or ethics
(9%), or to leaving things to nature or chance (9%). The main
reason given for judging such tests as useful rather than harm-
ful was because they could provide information helpful in plan-
ning ahead (74%). There were no differences in these open-
ended responses by race or ethnicity, but the questions were
asked of small numbers of respondents only.
Preferences for genetic tests for adults
An increasing number of genetic tests can be used to predict
the likelihood that an adult individual will develop a particular
disease. (As of May, 2002, there were genetic tests for over 900
inherited conditions, 556 of them available on a clinical basis;
323 of those were offered as prenatal tests, and the number of
such tests is growing; Genetests.Geneclinics: Genetics Infor-
mation Resource. Copyright, University of Washington and
Children’s Health Care System, Seattle, 1995. Available at
http://www.genetests.org or http://www.geneclinics.org, ac-
cessed on May 23, 2002.) Some of these diseases, such as breast
and colon cancer, are not invariably fatal and an early test may
allow the person to take preventive action; others, such as Hunt-
ington disease, are invariably fatal, but an early test may per-
mit the affected individual to engage in advance planning.
Both types of tests carry certain risks having nothing to do
with the disease itself. For example, there may be implications
for employment or insurability if the results become known to
one’s employer or insurance company (e.g., Canter, 1984;
Draper, 1986, 1991; Uzych, 1986; Holtzman, 1989; Billings et
al., 1992; Institute of Medicine, 1994). And if the test results
are shared, they may confer unwanted knowledge on siblings
or other family members.
Preferences for genetic testing among adults have been eval-
uated only infrequently. However, Andrykowski et al. (1997)
note that 82% of Kentucky residents interviewed by telephone
in 1995 said that they would undergo a blood test for cancer if
it was inexpensive and easy to perform, and in a similar sur-
vey of Kentucky residents a year earlier, Andrykowski and col-
leagues (1996) found that 87% expressed an interest in learn-
ing about a genetic predisposition to cancer in general, and 93%
for learning about breast cancer in particular. A telephone sur-
vey by Croyle and Lerman (1993) of Utah residents in 1990
found that 83% expressed an interest in genetic testing for colon
cancer. A Canadian survey carried out in Ontario at about the
same time, however, found a much smaller proportion, 39.9%,
expressing such an interest. That proportion was further reduced
when a number of qualifying conditions were introduced in sub-
sequent questions (Graham et al., 1998).
Reviewing questions asked on national surveys of the gen-
eral population, Singer et al. (1998, p. 636 and Tables 17 and
18) report that “the vast majority . . . would take a genetic test
capable of detecting a curable disease, and somewhat smaller
majorities say they would take such a test even if there were
no cure. Both percentages seem to be increasing over time.”
In the present survey, we asked similar questions about tests
for treatable and for fatal illnesses, phrasing each both in a spe-
cific and a more abstract version. The following questions were
asked about a treatable illness: “If a genetic test could tell you
whether or not you are likely to get a treatable genetic disease
later in life, would you personally want such a test or not?” or
“Colon cancer is a disease that can be treated. There is a sim-
ple blood test for some of the genetic changes that increase the
chance of getting colon cancer. Would you personally want to
have such a test, or not?” A random half of the sample was
asked each version of the question. The questions about tests
for an untreatable illness were as follows: “Some genetic dis-
eases are not treatable. If a genetic test could tell you whether
or not you will develop a serious, disabling disease later in life
for which there is no treatment or cure at present, would you
personally want to have such a test or not?” or “Some genetic
diseases are not treatable. Huntington disease is a progressive,
disabling genetic disease that usually develops when people are
in their forties. It affects the brain and cannot be treated or
cured. Would you personally want to have such a test or not?”
Among Latino respondents, 76.5% said they would want to
be tested for a “treatable genetic disease” (see Table 2). This is
a higher percentage than either African-American or White re-
spondents, but the differences are reduced to insignificance
when other demographic characteristics are controlled. When
the question is asked about colon cancer, a specific treatable
genetic disease, more than 80% of each of the three groups pro-
fess a desire to undergo testing, and again there are no signif-
icant differences by race/ethnicity.
The proportions expressing a desire to be tested for a dis-
ease for which no treatment or cure is available are, not unex-
pectedly, much lower. Some 58% of African-American re-
spondents and 61% of Latino respondents say they would want
to be tested for an untreatable illness, but only 43% of White
respondents—differences that are statistically significant even
with other demographic characteristics controlled. The same
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pattern holds when the question is asked about Huntington, a
specific untreatable disease. Thus, once again, there is no indi-
cation that African-American or Latino respondents are less
likely to want genetic testing than White respondents.
Beliefs and attitudes with respect to other 
aspects of genetic testing
We asked two questions about the use of deoxyribonucleic
acid (DNA). The first was designed to probe beliefs about the
relative accuracy of fingerprint and DNA evidence for purposes
of identification. Although the media have publicized many
cases in which convicted criminals have been freed on the ba-
sis of DNA evidence, the practice of collecting DNA from sus-
pects and storing it for future use has also aroused protests, es-
pecially among African-Americans.
There were significant differences between White and
African-American respondents in their evaluation of the use of
DNA evidence compared with fingerprints, with White re-
spondents rating it as better. Differences between White and
Latino respondents were not significant with other demographic
variables controlled (see Table 3).
The second question asked about proposals to collect a sam-
ple of DNA from each newborn and store it in a data bank for
subsequent use in criminal investigations as well as medical re-
search. The question deliberately included a reference to ben-
efits (medical research) as well as possible costs (criminal in-
vestigations), requiring respondents to balance them when eval-
uating the proposal. With other demographic characteristics
included as controls, there were no significant differences be-
tween White respondents and either of the other two race/eth-
nic groups.
Cloning
Respondents were also asked several questions about
cloning, a process in which genetic material from one individ-
ual is implanted into an unfertilized egg, resulting in the de-
velopment of an embryo which is a duplicate, or clone, of the
individual. At present, the cloning of animals is permitted by
law, and a ban on human cloning that passed the House of Rep-
resentatives in 2001 has so far been blocked in the Senate (as
of early 2004).
The first series of questions defined cloning and then asked
whether the respondent believed cloning animals should be al-
lowed to continue or not; those who thought it should not be
allowed to continue were asked whether the ban should be tem-
porary or permanent, and whether they were opposed to cloning
for religious or moral, or for other, reasons.
African-American respondents were significantly more
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TABLE 2. ATTITUDE TOWARD GENETIC TESTING FOR ADULTS, BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
African-Americana Latinoa Whitea African-American Latino
Attitude (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
Want test for treatable disease 64.8% 76.5% 64.7% NSc NSc
Want test for colon cancer 83.9% 81.2% 80.8% NSc NSc
Want test for untreatable disease 57.6% 61.3% 42.6% ,0.01 ,0.10
Want test for Huntington Disease 56.4% 60.2% 43.8% ,0.05 ,0.01
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
cNS, Not significant.
TABLE 3. ATTITUDE TOWARD OTHER ASPECTS OF GENETIC TESTING BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
African-Americana Latinoa Whitea African-American Latino
Attitude (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
DNA better than fingerprints 48.3% 58.3% 70.2% ,0.01 NSc
How acceptable is it to store DNA? 20.3% 26.0% 24.0% NSc,d NSc,d
(Very acceptable)
Should research on animal cloning 23.7% 38.6% 45.8% ,0.01 NSc
be allowed to continue?
(Yes)
Should research on human cloning 16.3% 22.9% 19.2% NSc NSc
be allowed to continue?
(Yes)
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
cNS, Not significant.
dThese equations treat the dependent variable as an ordered logit.
likely to be opposed to cloning animals than either Latino or
White respondents. Only 23.7% of the African-American sam-
ple thought experiments on animal cloning should continue,
compared with 38.6% of the Latino and 45.8% of the White
sample. African-American respondents were significantly more
likely to cite religious and moral reasons for opposing contin-
ued cloning of animals than they were to cite other reasons.
When the same questions were asked about the cloning of
human embryos, the proportion opposed to continued research
increased significantly, with about 80% of all three race/ethnic
groups expressing opposition. Differences among the three
groups were not significant. Moral and religious reasons were
cited significantly more often than other reasons by those op-
posed to continued research in this area. Thus, unlike prefer-
ences for prenatal and adult genetic testing, attitudes toward
other aspects of genetic testing show either no differences by
race or ethnicity or reveal more favorable attitudes among
Whites than among either of the other groups.
Potential barriers to testing
So far, we have examined preferences for prenatal and adult
genetic testing and for abortion in the case of a serious genetic
fetal defect, as well as attitudes toward other aspects of genetic
testing. Such differences as were found among the three
race/ethnic groups generally indicated a greater preference for
prenatal and adult genetic testing among nonwhite respondents.
In this section, we examine what we call potential barriers to
testing, in an effort to account for the fact that although Lati-
nos and African-Americans express a greater preference for
testing, they appear to avail themselves of testing less often than
Whites. The following barriers are considered: Information
about genetic testing; knowledge and interest; insurance cov-
erage; concerns about the possible misuse of genetic testing;
concerns about privacy; and confidentiality and trust.
Information about genetic testing
Sources of Information: One potential barrier to the use of
genetic testing is simply lack of accurate information about
what tests are available. The interview began with several gen-
eral information questions. These asked how closely the re-
spondent followed news about science and health, and which
sources of information were used for getting such news. Re-
spondents interviewed in Spanish were significantly less likely
to follow such news than those interviewed in English, a fact
that may have a bearing on their attitudes. We return to this in
the discussion section.
All those who reported more than minimal exposure to news
about science and health were asked whether or not they used
each of the following sources: television, radio, newspapers or
magazines, the Internet, friends or family members, a religious
group or organization, and their doctor. They were also asked
which was the most important source for them. For all three
race/ethnic groups, doctors were the most important source—
37.9% of White respondents, 50% of African-American re-
spondents, and 32.3% of Latino respondents named their doc-
tor as the most important source (data not shown). For the latter
two groups, however, television is the next most frequently
cited most important source, by 31.9% of Latinos and 24.4%
of African-Americans, respectively; for White respondents,
newspapers and magazines, named by 30.4%, are second in im-
portance to their doctor. The other sources were cited as most
important by very small percentages of each of the three groups.
Knowledge and interest: A series of seven factual questions
assessed respondents’ knowledge about genetic testing. These
were asked very early in the interview, before any other ques-
tions that might inadvertently provide respondents with cues to
the correct answers. These questions were: “As far as you know,
is each of the following statements about the uses of genetic
testing true or false, or are you not sure? Genetic testing can be
used in adults to find out if they have a greater than average
chance of developing certain kinds of cancer (T); Genetic test-
ing can be used in adults to find out if they have a greater than
average chance of developing depression (F); Genetic testing
can be used in adults to predict whether a person will have a
heart attack (F); Genetic testing can be used during pregnancy
to find out whether the baby will develop sickle cell disease or
cystic fibrosis (T); Gene therapy is currently being used to cor-
rect many of the defects found through genetic testing (F);
Sickle cell anemia is a genetic blood disease that affects mainly
African-Americans. As far as you know, is there a cure for
sickle cell anemia? (No); Cystic fibrosis is a genetic disease
that may lead to serious problems with breathing and digestion.
As far as you know, is there a cure for cystic fibrosis? (No)”
Respondents answered less than half the questions correctly,
on average, and there were significant differences among the
three race/ethnic groups, with White respondents answering sig-
nificantly more questions correctly than either of the other
groups. On an index omitting the two questions about cures for
specific diseases, only the differences between African-Amer-
ican and White respondents remained significant (see Table 4).
After the conclusion of the interview, interviewers were
asked to rate respondents’ interest in, and understanding of, the
survey topic. White respondents were rated as significantly
more interested than African-American respondents, as well as
having a significantly better understanding. Thus, there is some
support for the possibility that lack of information may consti-
tute one barrier to utilization of genetic testing on the part of
African-American respondents.
Respondents who identified themselves as Latino and who
were interviewed in Spanish were significantly less accurate
with respect to the genetic knowledge questions than those in-
terviewed in English, and they were also rated by interviewers
as significantly less likely to have an understanding of the topic
than those interviewed in English. We return to the implica-
tions of this in the discussion section.
Insurance coverage of genetic testing
Another potential barrier to testing on the part of African-
American and Latino respondents is lack of insurance cover-
age for such tests. At present, there is considerable variability
in insurance companies’ coverage for genetic testing, and the
conditions under which coverage applies may also be ambigu-
ous. Medicare does not cover basic genetic testing. Medicaid
covers newborn screening and a nominal number of other ge-
netic tests dealing with cancer diagnosis. Many genetic tests,
however, are not covered.
We asked respondents in our sample about the kind of health
insurance they and their families had. As can be seen from Table
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5, approximately 30% of the three groups were covered by
Medicare. A smaller proportion reported coverage by Medic-
aid, with African-Americans again significantly more often re-
porting such coverage. Some 85% of the White sample reported
access to private health insurance, a significantly higher pro-
portion than either the African-American or the Latino sample.
In general, minority populations are more likely to be covered
by Medicare or Medicaid, whereas White respondents are more
likely to have private health insurance. Thus, there are finan-
cial as well as informational barriers to the utilization of ge-
netic testing by Latino and African-American populations.
We asked all respondents whether they thought private health
insurance plans should pay for prenatal genetic tests, and
whether publicly funded programs such as Medicaid should pay
for such tests. Not unexpectedly, groups more favorable toward
prenatal testing were also more likely to believe that insurance,
whether public or private, should cover the expense of such
tests. White respondents, who were less likely to say they would
want prenatal testing, were significantly less likely than either
Latino or African-American respondents to favor coverage of
such tests by insurance companies. When we asked whether
abortion in case of fetal defect should be covered by insurance,
whether private or public, White respondents were again sig-
nificantly less likely to favor such coverage than Latino or
African-American respondents. Whether or not respondents
themselves had any kind of insurance did not significantly af-
fect their answer to the question about paying for abortion (with
demographic variables controlled), but it did affect answers to
the question about paying for prenatal testing. Those with in-
surance of some kind were significantly more likely to say that
insurance should cover the costs of such tests (data not shown).
Concerns about the possible misuse of genetic testing
So far, we have considered informational and financial bar-
riers to genetic testing. We turn next to some potential attitu-
dinal barriers.
Early in the interview, respondents were asked several ques-
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TABLE 5. INSURANCE COVERAGE AND ATTITUDES BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
African-Americana Latinoa Whitea African-American Latino
Coverage and attitudes (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
Has Medicare 29.3% 26.6% 30.0% ,0.01 NSc
Has Medicaid 21.1% 13.8% 8.4% ,0.01 NSc
Has private insurance 70.1% 61% 85% ,0.01 ,0.01
Has any insurance 89.7% 80.3% 93.4% NSc NSc
Should insurance pay for prenatal 3.47 3.37 3.00 ,0.01 ,0.01
genetic testing/counseling?
(Mean score on four-item index)
Should insurance pay for abortion? 1.09 1.21 1.03 ,0.01 ,0.01
(Mean score on two-item index)
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
cNS, Not significant.
TABLE 4. KNOWLEDGE , INTEREST, AND UNDERSTANDING ABOUT GENETIC TESTING, BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
Knowledge, interest, and African-Americana Latinoa Whitea African-American Latino
understanding (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
Follow news about science 27.1% 21.6% 19.5% ,0.10c NSc,d
very closely
Knowledge index (seven items) 3.18 2.70 3.39 ,0.05 ,0.01
(Mean # accurate)
Knowledge index (five items) 1.78 1.82 1.94 ,0.05 NSd
(Mean # accurate)
Very interested in survey topic 41.1% 45.8% 52.2% ,0.01c NSc,d
Excellent understanding of survey topic 35.7% 35.1% 45.5% ,0.01 NSd
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
cThese equations treat the dependent variable as an ordered logit.
dNS, Not significant.
tions about their expectations for the future of genetic testing.
Placement of these questions was designed to prevent later
questions from influencing the responses. The first such ques-
tion asked:
The next questions are about genes and genetic testing.
Genes are the blueprint for how everything in the body
works. Genetic testing makes it possible to tell whether or
not someone is likely to develop certain diseases or con-
ditions. Some people say genetic testing is a wonderful
medical advance. Others think it may cause trouble. What
about you—do you think genetic testing will do more good
than harm, or more harm than good?
With other demographic variables controlled, Latinos were
significantly more likely than Whites to believe that genetic
testing would do more harm than good, and African-Americans
were marginally more likely to do so (see Table 6). There is,
thus, an indication that both Latino and African-American re-
spondents have more reservations about the future of genetic
testing than White respondents do.
An open-ended question probed the reasons for the respon-
dent’s belief that genetic tests would do more good than harm or
more harm than good. The most common reasons for believing
such tests would do more good than harm were expectations that
they would lead to cures for, or prevention of, disease (39%) or
would provide useful knowledge (36%); some respondents based
their answer on past scientific advances or general faith in science
and technology (7%). The chief reasons for believing that genetic
tests would bring more harm than good were reasons based on
God, religion, or ethical beliefs, or the belief that one should let
nature take its course (26%). Other reasons involved the belief
that such tests would lead to eugenic selection or discrimination
(15%) or cloning or other misuse (20%).
Following these very general questions came eight state-
ments designed to probe beliefs about the potential misuse of
genetic testing. Respondents were asked whether they strongly
agreed, somewhat agreed, somewhat disagreed, or strongly dis-
agreed with each of the following statements, which were based
on comments made in discussion groups composed entirely of
African-American or Latino participants, conducted before the
present survey was fielded (cf. Singer et al., 2001).
Genetic testing during pregnancy is a good thing because
it allows people to choose to have the children they really
want.
Genetic testing will lead to discrimination against peo-
ple who are not perfect.
Anonymous genetic testing, where no record is kept of
the person’s name, should be available to people who want
it.
Genetic testing will mostly benefit people who already
have a lot of advantages.
Information from genetic tests is likely to be misused.
Genetic testing is the first step to getting rid of people
the government considers undesirable.
Scientists are creating unrealistic hopes about how soon
cures will be found for genetic diseases.
Research on genes is taking away money that should be
used for other health problems
We created an Index of Negative Use that summed responses
to these statements, with strong agreement scored 2, agreement
1, and all other responses, 0 (scoring on the first and third items
was reversed). Thus, high scores indicate very negative beliefs
about the consequences of genetic testing, and low scores in-
dicate the relative absence of such beliefs.
Scores on this index indicated that both African-American
and Latino respondents had significantly more negative beliefs
about the consequences of genetic testing than White respon-
dents, and such beliefs, along with fewer informational and fi-
nancial resources, may well counteract the greater preferences
they express for both prenatal and adult genetic testing.
Concerns about privacy and confidentiality
Concerns about the confidentiality of test results, and about
possible consequences of such breaches for employment and
insurance, have been mentioned in connection with preferences
for adult genetic testing, above. We asked a series of questions
in this study that were relevant to such concerns. For each of
the adult-onset diseases for which we asked whether the re-
spondent would want to be tested, we also asked, “Suppose a
test shows that a person will probably develop [it]. The next
questions are about who you think has the right to know this
information.” In each case, we asked (1) about the person’s
spouse or life partner; (2) a fiancé or a future life partner; (3)
other immediate family, like brothers and sisters; (4) the per-
son’s employer; and (5) the person’s health insurance company.
The belief that others who might be affected by one’s propen-
sity for illness had a right to genetic test results was measured
by the sum of Yes responses to these questions.
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TABLE 6. CONCERNS ABOUT MISUSE BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
African-Americana Latinoa Whitea African-American Latino
Concerns about misuse (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
General attitude toward genetic testing 18.2% 15.3% 12.4% ,0.10 ,0.05
(% harm . good)
“Negative Use” Index 6.34 5.89 4.96 ,0.01 ,0.01
(Mean score)
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
Using this measure, White respondents were the most pro-
tective of privacy of the three race/ethnic groups, scoring con-
sistently and significantly lower than either of the other two
groups (see Table 7). Wertz (1998), reporting similar findings,
has interpreted this as reflecting a greater sense of obligation
toward friends and family members on the part of African-
American and Latino respondents. Therefore, we examined
each of the items of the “right to know” index separately, rea-
soning that respondents might feel an obligation toward family
members but not necessarily toward employers or insurance
companies. However, for each item of the “right to know” in-
dex, African-American and Latino respondents were more
likely than White respondents to say others had a right to know
the results of testing. Thus, the interpretation of this pattern of
responses is somewhat ambiguous and may reflect “yea-say-
ing” rather than felt obligation toward friends and family mem-
bers. The reasons for these differences in responses clearly need
further research.
Certainly, with respect to other privacy-related attitudes,
African-American and Latino respondents tend to express views
that indicate greater concerns. The first question about privacy
asked respondents whether they agreed strongly, somewhat,
only a little, or not at all with the statement, “People’s rights
to privacy are well protected.” Significantly more African-
Americans and Latinos expressed strong disagreement with this
statement. African-Americans were significantly more likely to
express strong agreement with the statement, “The government
already knows more about me than it needs to” (there were no
significant differences between Latinos and Whites). Finally,
both African-American and Latino respondents were signifi-
cantly more likely to say that their phone had ever been tapped.
In short, African-American and Latino respondents give some
evidence of being more concerned about personal privacy than
White respondents, and these concerns may work against their
seeking out both prenatal and adult genetic testing.
Confidence and trust
At the very end of the interview, respondents were asked
how much confidence they had in the people running the gov-
ernment in Washington, the leaders of science, and the corpo-
rations that make and sell genetic tests. They were also asked
how much they trusted their doctor to keep medical informa-
tion about them private.
African-Americans are often assumed to be more distrustful
of government and medical institutions than Anglo-Americans
are, and indeed this is borne out in the current study. On an in-
dex combining responses to the three confidence questions,
White respondents expressed significantly more confidence
than African-American respondents did (see Table 8). They
were also more likely to trust their doctor to keep information
about them private. The responses of Latinos did not differ sig-
nificantly from those of other Whites.
A similar pattern was observed on three other statements mea-
suring efficacy and trust. The statements were the following: Most
people can be trusted; people like me don’t have any say about
what the government does; I don’t think public officials care much
what people like me think. For each of these, respondents were
asked to indicate whether they strongly agreed, somewhat agreed,
somewhat disagreed, or strongly disagreed. On all of these,
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TABLE 7. CONCERNS ABOUT PRIVACY BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
African-Americana Latinoa Whitea African-American Latino
Concerns about privacy (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
Who has the right to know results 3.13 3.16 2.66 ,0.01 ,0.10
of test for treatable illness?
(Mean score on five-item index)
Who has the right to know results 3.41 3.28 2.66 ,0.01 ,0.01
of test for colon cancer?
(Mean score on five-item index)
Who has the right to know results 3.18 3.16 2.48 ,0.01 ,0.01
of test for untreatable illness?
(Mean score on five-item index)
Who has right to know results of  3.44 3.23 2.69 ,0.01 ,0.05
test for Huntington Disease?
(Mean score on five-item index)
Privacy is well protected 43.6% 34.7% 30.1% ,0.01 ,0.10
(Strongly disagree)
Government knows too much 68.2% 50.0% 50.2% ,0.01 NS
(Strongly agree)
Phone ever tapped? 37.3% 27.8% 15.8% ,0.01 ,0.01
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
African-American respondents indicated significantly less effi-
cacy and trust than White respondents, whereas Latino respon-
dents did not differ significantly from Whites on three of the four.
It has been hypothesized that absence of trust in American
institutions is what leads African-Americans to have more neg-
ative attitudes toward genetic testing than Whites. We tested
this hypothesized mediating role of confidence in societal in-
stitutions on the relationship between race and a number of the
dependent variables that reveal more negative attitudes on the
part of African-Americans, including expectations about the fu-
ture of genetic testing, the negative use index, and approval of
animal cloning. Adding scores on the confidence index to the
other predictor variables eliminated the significant difference
between Whites and African-Americans on expectations about
the future of genetic testing, but it did not eliminate such dif-
ferences on either of the other variables. Clearly, confidence in
institutions does not in itself explain the more negative re-
sponses of African-Americans to these items.
DISCUSSION AND CONCLUSIONS
It is clear from our study that African-American and Latino
respondents are, if anything, more eager to avail themselves of
genetic testing, whether prenatal or adult, than White respon-
dents are. Their apparently lower utilization of this technology
cannot, therefore, be attributed to negative attitudes toward test-
ing itself. At the same time, African-Americans and Latinos
have lower average income than Whites, and are less likely to
carry private health insurance. Thus, their ability to avail them-
selves of genetic testing is reduced relative to Whites.
In addition, however, African-Americas, in particular, share
a number of beliefs that may conflict with their desire for ge-
netic testing and discourage their use of it. They are less knowl-
edgeable about what such tests can and cannot do, they are more
concerned about privacy vis-à-vis the government, and they are
more concerned about the possible misuses of genetic infor-
mation. They express less confidence in American institutions
and less trust in their doctor and in people in general, and less
of a sense of political efficacy. These attitudes may well over-
ride their desire for genetic testing in any given situation.
It has been suggested that their greater lack of confidence in
American institutions is responsible for some of the differences
between the responses of African-American and White re-
spondents on this survey. As we have seen, this appears to be
true for expectations about whether such testing will do more
good than harm in the future, but not for concerns about pos-
sible misuses of genetic information, as measured by the Neg-
ative Use Index.
With respect to these attitudinal barriers to testing, Latino
respondents differ less from White respondents than African-
American respondents do. They do not differ significantly from
Whites on the five-item knowledge index, and they are no less
likely than White respondents to be described by interviewers
as “very interested” in the survey topic and as displaying “ex-
cellent understanding.” Nor do Latinos differ from Whites on
various measures of confidence in institutions, trust, or politi-
cal efficacy. They do, however, share African-Americans’ con-
cerns about privacy as well as about the potential misuse of ge-
netic information.
For both Latinos and African-Americans, religious factors
may play a role in reducing utilization of genetic testing. Fre-
quency of church attendance is a significant negative predictor
of preferences for testing as well as many other attitudes rele-
vant to genetic technology, and African-Americans tend to at-
tend church more frequently than either of the other groups.
Self-identification as a Catholic is likewise related to negative
attitudes toward testing, and Latinos are more likely to identify
themselves as Catholic than either of the other groups. Although
religion and religious attendance were controlled in all of the
attitudinal analyses reported here, these factors may effectively
reduce the utilization of genetic testing by African-Americans
and Latinos.
Several findings reported in this article clearly call for fur-
ther research. For example, although they express more con-
cern about the potential misuse of genetic information, both
African-American and Latino respondents seem to be less sen-
sitive than White respondents to some possible abuses of ge-
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TABLE 8. CONFIDENTIALITY, EFFICACY, AND TRUST BY RACIAL/ETHNIC IDENTIFICATION
p Value p Value
Confidentiality, African-Americana Latinoa Whitea African-American Latino
efficacy, and trust (n 5 375) (n 5 428) (n 5 960) vs. Whiteb vs. Whiteb
Confidence in institutions 1.99 2.04 2.41 ,0.01 NSc
(Mean score on three-item index)
(Low 5 less confidence)
Trust your MD to keep information 50.9% 48.2% 59.1% ,0.01 NSc
about you private
(A great deal)
Trust people (strongly disagree) 32.3% 34.4% 12.7% ,0.01 ,0.01
Efficacy (two item index; lower score 0.79 0.65 0.56 ,0.01 NSc
means more efficacy)
aPercentages and means are based on unweighted data and do not control for demographics.
bp values are based on multiple regressions that control for other variables and reflect two-sided tests of significance.
cNS, Not significant.
netic testing. They are less likely to consider prenatal testing
for hair color, height, or weight as harmful, and less likely than
White respondents to say that testing for genetic predispositions
to behavioral characteristics like homosexuality or criminal be-
havior would do more harm than good. In response to ques-
tions not included in the present analysis, they are also less
likely to say employers should not be allowed to administer ge-
netic tests to prospective employees or to refuse to hire those
whose tests show a predisposition to certain forms of heart dis-
ease and cancer. Research is needed to clarify the meaning of
these responses, and their apparent contradiction with other re-
sponses indicating concern about potential misuse of genetic
testing.
White respondents also tend to be much more restrictive in
giving others access to private genetic information, even
though, in response to a general question, they express less con-
cern about privacy than African-American or Latino respon-
dents do. It is possible that this is a matter of framing—perhaps
African-American and Latino respondents understand the ques-
tion about “who should have a right” to genetic information as
conferring a benefit on others, whereas White respondents tend
to see it as a violation of privacy, instead (cf. Wertz, 1998). As
noted earlier, this, too, is an area where further research is
needed.
On many of these measures, Latino respondents interviewed
in Spanish differed significantly in their responses from those
interviewed in English. They were even more likely to say they
would want both prenatal and adult genetic tests, and they were
more likely to say they would want to abort the fetus in case
of a serious genetic defect. They were significantly less likely
to think testing for things like height, weight, hair color, crim-
inality, or homosexuality would do more harm than good, and
significantly more likely to believe that genetic testing would
bring more good than harm in the long run. At the same time,
they do not differ from Latino respondents interviewed in En-
glish in their concerns about possible misuse of genetic infor-
mation or about privacy, even though they express more con-
fidence in American institutions than respondents interviewed
in English.
It is difficult to interpret this pattern of results. Latino re-
spondents interviewed in Spanish are less likely to follow news
about science and health, scored lower on the seven-item knowl-
edge index, and were rated by interviewers as having less un-
derstanding of the survey topic than those interviewed in En-
glish. They also had significantly lower levels of education
(54%, for example, had less than 12 years of education, com-
pared with 15% of those interviewed in English, and 8.8% had
graduated from college, compared with 27.3% of those inter-
viewed in English). One possibility, therefore, is that the re-
sponses described above simply reflect imperfect understand-
ing of the questions, and a tendency to select the first response
alternative offered by the interviewer.
Another possibility is that administering the questionnaire in
Spanish had unanticipated consequences even though the trans-
lated instrument was reviewed by a bilingual interviewer and
administered by interviewers fluent in both Spanish and En-
glish.
Unfortunately, we simply do not have enough information to
decide among these alternatives, and here too much more re-
search is clearly needed. Most survey questionnaires are not trans-
lated into another language, with unknown consequences for the
interpretation of results. (One possible consequence, of course,
is that respondents not fluent in English are not interviewed at
all.) We need to understand better both how to render questions
and responses equivalent in other languages and how to interpret
any remaining differences between respondents of similar ethnic
background who are interviewed in different languages.
On the basis of the present survey, we cannot explain why
African-Americans and Latinos differ from White respondents
with respect to some of the attitudes expressed about genetic
testing. However, although we cannot be sure of the reasons
for differences where these exist, the survey clearly indicates
that it is not less desire for the potential benefits of genetic test-
ing that accounts for the lower utilization of this technology by
African-Americans and Latinos. Rather, this seems to be at-
tributable to a combination of fewer resources, less access to
information, and greater concerns for the possible negative con-
sequences of such tests.
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